There’s no doubt that the Sunshine Act provisions of the Affordable Care Act, which require pharmaceutical companies to track and publicly report what they spend on U.S. healthcare providers, will make life more difficult for life sciences meeting planners. But it gets even more complicated when you take your meetings outside the U.S. and have to deal both with the rules of the event’s host country and those of your healthcare provider attendees. As Peter Burberry, senior ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Printer-friendly, you'll also gain access to exclusive premium content.

Already registered? here.